Court Rules Pfizer (PFE) Can Face Suits Related to Asbestos Exposure -Reuters
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $25.05 -0.36%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.8%
Join SI Premium – FREE
Shares of Pfizer (NYSE: PFE) have ticked lower over the last few minutes as Reuters is reporting a US court has ruled the company can face lawsuits related to asbestos exposure.
The stock is flirting with the 200-day simple moving average. Shares are up 0.6 percent to $22.19, but well off session highs.
The stock is flirting with the 200-day simple moving average. Shares are up 0.6 percent to $22.19, but well off session highs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer temporarily discontinues premarin vaginal cream in India, citing supply challenges - Reuters
- Kieran Shanahan, COO Walmart U.S., Will Leave the Company, Memo Says - WSJ
- CVS Health reaches FTC settlement over pharmacy benefit practices
Create E-mail Alert Related Categories
Litigation, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
